MGI Empowerment Program
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

27

Jan 2023

Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment

Nogra Pharma a clinical stage biotechnology company developing innovative therapeutics for immuneinflammatorymediated diseases today announces it has entered into an outlicensing agreement with Torii Pharmaceutical Co Ltd Torii TSE to further develop and commercialise NACGED in Japan for the treatme...

27

Jan 2023

Elixirgen Therapeutics Enters Memorandum of Understanding with Hitachi Global Life Solutions for the Development of Micro GMP Suites for Cell Therapy Administration

Elixirgen Therapeutics Inc a clinicalstage biotechnology company focused on the discovery development and commercialization of therapies using its controllable selfreplicating RNA csrRNA platform today announced that it has entered a memorandum of understanding with Hitachi Global Life Solutions Inc...

25

Jan 2023

Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma

Stevanato Group SpA a leading global provider of drug containment and delivery solutions to the pharmaceutical biotechnology and life sciences industries announced its latest collaboration with Transcoject GmbH a medical device and pharma packaging solutions company The collaboration will enable Ste...

25

Jan 2023

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia

Alvotech and Bioventure a wholly owned subsidiary of GlobalOne Healthcare Holding LLC GHH the healthcare division of Yas Holding LLC today announced that the Saudi Food Drug Authority SFDA has approved the manufacturing and distribution of AVT a biosimilar for Humira adalimumab which is commonly in...

24

Jan 2023

IntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countries

IntelGenx Corp a leader in pharmaceutical films announced today that it has entered into an exclusive supply agreement for RIZAPORT the Product with ARWAN Pharmaceuticals Industries Lebanon sal ARWAN in various countries in the Middle East and North Africa MENA region including Lebanon Kuwait Saudi...

24

Jan 2023

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal

CytoReason a leader and pioneer in computational disease modeling today announced an expansion of its collaboration with Sanofi The multiyear collaboration will further fuel Sanofis target discovery efforts via CytoReasons AI platform in the field of inflammatory bowel disease IBD to identify patien...

press releasesRead more...

26

Jan 2023

Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

Centessa Pharmaceuticals plc a clinicalstage pharmaceutical company that aims to discover and develop medicines that are transformational for patients today announced that it has received clearance of its Investigational New Drug IND application from the US Food and Drug Administration FDA to initia...

26

Jan 2023

Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III

ProBioGen today announced that a Novartis clinical candidate using its antibodydependent cellular cytotoxicity ADCC technology GlymaxX has reached Phase III ProBioGens mission is to contribute towards the development of medicines against complex diseases Therefore ProBioGen wants to particularly emp...

24

Jan 2023

Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases

Core One Labs Inc in followup to its press release dated September is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd Akome has finalized study parameters and signed a contract with Fundaci Bosh I Gimpera in representation of Universitat de Barcelona the University of Barcel...

24

Jan 2023

Aspargo Receives Regulatory Approval to Market Sildenafil Spray in Germany, Ireland, and The Netherlands

Aspargo Laboratories Inc a privately held specialty pharmaceutical company focused on commercializing innovative formulations of leading tablet medications announced today that the German Federal Institute for Drugs and Medical Devices has authorized the marketability of Hezkue mg per actuation ora...

23

Jan 2023

BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study

BiondVax Pharmaceuticals Ltd a biotechnology company focused on developing manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases today announced additional results in a preclinical proofofconcept study of its innovat...

23

Jan 2023

First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated

OxSonics Therapeutics a clinicalstage medtech company focused on transforming cancer treatment through SonoTran its proprietary ultrasoundbased drug delivery platform today announces that firstinhuman clinical data demonstrated that SonoTran is safe and welltolerated with consistent

EventsRead more...

30 - 01

Jan 2023

Precision Medicine in Inflammatory Bowel

Embassy Suites by Hilton Boston at Logan Airport

31 - 02

Jan 2023

08 - 09

Feb 2023

Annual RNA Therapeutics Conference

Copthorne Tara Hotel London Kensington

14 - 16

Feb 2023

CRISPR AgBio Congress 2023

The Westin San Diego Bayview

14 - 16

Feb 2023

22 - 23

May 2023

Gynecology and Obstetrics

Scientex Conference
Tokyo

TOP ARTICLES

  • 4

    Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease

    Ruchi Chawla

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Varsha Rani

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Mohini Misra

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

    Krishan Kumar

    Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), India

KNOWLEDGE BANK

EDITORIAL SECTION

  • STRATEGY

    THE ECOSYSTEM PARADIGM

    To an ecologist an ecosystem is a biological community of interacting organisms and their physical environment This concept helps us to see that ecosystems in the life science industry are not simply subparts or the market or the industry They have wide boundaries and those boundaries blur and overlap with other ecosystems

  • RESEARCH DEVELOPMENT

    INTEGRATIVE ASSOCIATIVE CLASSIFICATION FOR CANCER BIOMARKER DISCOVERY

    Biomarkers or biological markers cover a wide range of substances that can be measured from body tissues cells blood or fluid For instance a cell expresses genes when they are required for biological processes and the measurement of gene expressions under different physiological conditions provide essential clues of gene functions Therefore biomarkers play essential...

  • MANUFACTURING

    Sustainable Packaging

    The top five drivers of this move to sustainability according to the Packaging Sustainability A Changing Landscape report from PMMI The Association for Packaging and Processing Technologies include brand perception competitive pressure environmental advocates topdown company culture and good stewards of the planet

  • Information Technology

    Creating Better Clean Label Soft Gels Without Gelatin Crosslinking

    Soft gels also known as soft capsules or soft caps are a highly popular pharmaceutical and nutraceutical dosage form with around units consumed every second globally A forecast by HJR Research predicts a CAGR of per cent over the next decade with the global market value expected to reach billion by During the same period the AsiaPacific region is projected to be t...